Skip to main content

Table 5 Studies excluded from analysis and their reasons for exclusion

From: The treatment of sarcoptic mange in wildlife: a systematic review

Treated species and reference Reason for exclusion
Vicuna (Vicugna vicugna), Gomez-Puerta et al. [53] No treatment outcomes are described
Giraffe (Giraffa reticulata), Alasaad et al. [54] Although reportedly successful on a population level, the study failed to recapture treated individuals and monitor their response to treatment
Capybara (Hydrochoerus hydrochaeris), Bernal et al. [55] No treatment outcomes are described
Agile wallaby (Macropus agilis), McLelland et al. [37] Although reportedly successful on an individual level, no post-treatment monitoring period is described
Gorilla (Gorilla beringei beringei), Graczyk et al. [22] Although reportedly successful on an individual level, the study fails to specify the duration of their post-treatment monitoring period
Iberian ibex (Capra pyrenaica), Pérez et al. [56] Limited treatment outcomes are described and there is no post-treatment monitoring period
Gray wolf (Canis lupus), Schultz et al. [17] Although reportedly successful on an individual level, the diagnosis of sarcoptic mange is not confirmed by skin scrapings
Wild ruminants, Yeruham et al. [16] Although reportedly successful on a population level, the study fails to specify the duration of their post-treatment monitoring period
Koala (Phascolarctos cinereus), Brown et al. [40] The study does not specify the number of animals treated or recovered
Koala, Barker [38] Although reportedly successful on an individual level, no post-treatment monitoring period is described